Showing results (61-70 of 105) with videos related to

Sort By:
Pageof 11
Thrombosis Research|March 7, 2017
Gender differences in patients with venous thromboembolism and five common sites of cancerFrancisco Martín-Martos, Javier Trujillo-Santos, Jorge Del Toro, et al.
Seminars in Thrombosis and Hemostasis|January 2, 2014
Antithrombotic treatment of splanchnic vein thrombosis: results of an international registryWalter Ageno, Nicoletta Riva, Sam Schulman, et al.
European Journal of Internal Medicine|March 15, 2016
Recurrence of venous thromboembolism in patients with recent gestational deep vein thrombosis or pulmonary embolism: Findings from the RIETE RegistryGiovanni Barillari, Ambrogio P Londero, Benjamin Brenner, et al.
Annals of Medicine|October 1, 2015
Rate and duration of hospitalization for deep vein thrombosis and pulmonary embolism in real-world clinical practiceFrancesco Dentali, Gianluca Di Micco, Matteo Giorgi Pierfranceschi, et al.
Thrombosis Research|July 22, 2020
Management and outcomes of cancer patients with venous thromboembolism presenting with thrombocytopeniaRamón Lecumberri, Pedro Ruiz-Artacho, Javier Trujillo-Santos, et al.
The American Journal of Medicine|December 24, 2017
Vitamin K Antagonists After 6 Months of Low-Molecular-Weight Heparin in Cancer Patients with Venous ThromboembolismChatree Chai-Adisaksopha, Alfonso Iorio, Mark A Crowther, et al.
Recenti Progressi in Medicina|August 12, 2003
[HIV protease inhibitors for the treatment of Kaposi's sarcoma]Gabriella Grosso, Cecilia Sgadari, Giovanni Barillari, et al.
International Journal of Molecular Sciences|November 11, 2022
Translational Implications for Radiosensitizing Strategies in RhabdomyosarcomaSilvia Pomella, Antonella Porrazzo, Matteo Cassandri, et al.
Cancer Treatment Reviews|October 23, 2024
Crosstalk and communication of cancer-associated fibroblasts with natural killer and dendritic cells: New frontiers and unveiled opportunities for cancer immunotherapySimone Ielpo, Francesca Barberini, Farnaz Dabbagh Moghaddam, et al.
Frontiers in Oncology|October 17, 2022
Radioresistance in rhabdomyosarcomas: Much more than a question of doseSimona Camero, Matteo Cassandri, Silvia Pomella, et al.
Pageof 11